Attended Regional Young investigator meeting, Hyderabad (18th – 19th August, 2018) at University of Hyderabad. Sapien Biosciences presented importance of primary human patient cultures, especially spheroid cultures (3D) for drug testing in Glioblastoma multiforme. We have identified molecules that demonstrated differential anti-cancer activity between 2D and 3D cultures in multiple functional readouts including inhibition of  […]

Excited to share that our Biobank at Sapien Biosciences and the patient cancer-derived cell models developed by Saarum Sciences Private Limited were covered by India Today as part of their COVER STORY devoted to innovation in India in the fight against Cancer (26th June issue). Kudos to Damayanti Datta for putting together a detailed summary for lay […]

NIPER here held a Pharma Industry Summit on 24th March 2017, bringing together many govt, academic, industry and trade groups to speak about life sciences entrepreneurship in Hyd. It was a great initiative by Dr. Nanduri who himself brings many years of industrial experience to NIPER. I particularly enjoyed the opportunity to moderate a panel […]

Jugnu Jain CEO at Sapien Biosciences & Saarum Sciences We offer 2 to 12 month research internships for bright diligent motivated graduate students in Biology, Biotech, Pharmacy, Bioinformatics, Health data analytics etc. The internships can be hands-on lab experience (molecular biology, cell biology, diagnostics, FACS etc.), or in medical data analysis, sample and clinical data […]

In this Post-Genomic era disease models are better understood from a Multi-Omics perspective

The most efficient, cost effective and comprehensive way to Re-Purpose your drugs

OncoPrime is a Phenotypic Drug Discovery Platform with a full array of characterizations relevant to disease phenotype and vital for studying the drug response in native state

Our flagship product / platform as a service for accelerating drug discovery with the help of primary cells isolated from tumor tissue biopsy

NEW ORLEANS—Larger tumor size is associated with high-grade pathology in patients with pT1a renal cell carcinoma (RCC), according to study findings presented at the 2015 American Urological Association annual meeting. Jeffrey A. Larson, MD, of the Washington University School of Medicine in St. Louis, Mo., and colleagues identified 975 patients with T1a N0M0 RCC treated […]